Inhibition of the invasion and migration of renal carcinoma 786‑o‑si3 cells in vitro and in vivo by Koelreuteria formosana extract

Lin,Chin‑Yin; Chen,Pei‑Ni; Hsu,Li‑Sung; Kuo,Dong  Yih; Chu,Shu‑Chen; Hsieh,Yih‑Shou

doi:10.3892/mmr.2014.2587

Inhibition of the invasion and migration of renal carcinoma 786‑o‑si3 cells in vitro and in vivo by Koelreuteria formosana extract

Authors:
- Chin‑Yin Lin
- Pei‑Ni Chen
- Li‑Sung Hsu
- Dong Yih Kuo
- Shu‑Chen Chu
- Yih‑Shou Hsieh
View Affiliations

Affiliations: Institute of Biochemistry and Biotechnology, Chung Shan Medical University, Taichung 40201, Taiwan, R.O.C., Department of Physiology, Chung Shan Medical University, Taichung 40201, Taiwan, R.O.C., Institute and Department of Food Science, Central Taiwan University of Science and Technology, Taichung 40601, Taiwan, R.O.C.
Published online on: September 22, 2014 https://doi.org/10.3892/mmr.2014.2587
Pages: 3334-3342

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Koelreuteria formosana ethanolic extract (KFEE) is obtained from natural plants that are endemic to Taiwan. In a previous study, it was demonstrated that KFEE inhibited low-density lipoprotein (LDL) and prevented oxidized LDL‑induced apoptosis in endothelial cells. In the present study, KFEE was shown to inhibit the invasion and migration of 786‑O‑SI3 renal cell carcinoma (RCC) cells while not exhibiting any cytotoxic effects. 786‑O‑SI3 cells were treated with KFEE at numerous concentrations of ≤100 µg/ml for 24 h. In order to examine the effects of KFEE, cells were then subjected to a series of assays for cell viability (MTT), wound healing migration, cell invasion and migration, gelatin zymography, casein zymography and immunofluorescence, as well as western blot analysis. KFEE was shown to decrease levels of matrix metalloproteinase‑2, phosphorylated (p‑)focal adhesion kinase Try925, p‑paxillin Ser178, p‑mitogen‑activated protein kinase kinase 1/2, p‑myosin light chain and p‑extracellular signal-regulated kinase 1/2 in 786-0-SI3 cells. Reduction of lung metastases was observed in KFEE-treated mice compared with vehicle‑treated control mice. KFEE inhibited the invasion of RCC cells and may have the potential for use as a chemopreventive agent against RCC metastasis.

View Figures

View References

1	Hutson TE and Quinn DI: Cytokine therapy: a standard of care for metastatic renal cell carcinoma? Clin Genitourin Cancer. 4:181–186. 2005. View Article : Google Scholar : PubMed/NCBI
2	Thoenes W, Störkel S and Rumpelt HJ: Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics. Pathol Res Pract. 181:125–143. 1986. View Article : Google Scholar : PubMed/NCBI
3	Al Otaibi M, Abou Youssif T, Alkhaldi A, Sircar K, Kassouf W, Aprikian A, Mulder D and Tanguay S: Renal cell carcinoma with inferior vena caval extention: impact of tumour extent on surgical outcome. BJU In. 104:1467–70. 2009.PubMed/NCBI
4	Choueiri TK, Garcia JA, Elson P, Khasawneh M, Usman S, Golshayan AR, Baz RC, Wood L, Rini BI and Bukowski RM: Clinical factors associated with outcome in patients with metastatic clear-cell renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy. Cancer. 110:543–550. 2007. View Article : Google Scholar
5	Amato RJ: Chemotherapy for renal cell carcinoma. Semin Oncol. 27:177–186. 2000.PubMed/NCBI
6	Yagoda A, Abi-Rached B and Petrylak D: Chemotherapy for advanced renal-cell carcinoma: 1983–1993. Semin Oncol. 22:42–60. 1995.
7	Cohen HT and McGovern FJ: Renal-cell carcinoma. N Engl J Med. 353:2477–2490. 2005. View Article : Google Scholar : PubMed/NCBI
8	Brugarolas J: Renal-cell carcinoma-molecular pathways and therapies. N Engl J Med. 356:185–187. 2007. View Article : Google Scholar : PubMed/NCBI
9	Athar U and Gentile TC: Treatment options for metastatic renal cell carcinoma: a review. Can J Urol. 15:3954–3966. 2008.PubMed/NCBI
10	Liu YH, Li ML, Hsu MY, et al: Effects of a Chinese herbal medicine, guan-jen-huang (Aeginetia Indica Linn.), on renal cancer cell growth and metastasis. Evid Based Complement Alternat Med. 2012:9358602012.PubMed/NCBI
11	Wang SC, Tang SW, Lam SH, et al: Aqueous extract of Paeonia suffruticosa inhibits migration and metastasis of renal cell carcinoma cells via suppressing VEGFR-3 pathway. Evid Based Complement Alternat Med. 2012:4098232012.PubMed/NCBI
12	Lee SK, Jung HS, Eo WK, Lee SY, Kim SH and Shim BS: Rhus verniciflua Stokes extract as a potential option for treatment of metastatic renal cell carcinoma: report of two cases. Ann Oncol. 21:1383–1385. 2010. View Article : Google Scholar
13	Lin CY, Chen PN, Hsieh YS and Chu SC: Koelreuteria formosana extract impedes in vitro human LDL and prevents oxidised LDL induced apoptosis in human umbilical vein endothelial cells. Food Chem. 146:299–307. 2014. View Article : Google Scholar : PubMed/NCBI
14	Abou Shoer M, Ma GE, Li XH, Koonchanok NM, Geahlen RL and Chang CJ: Flavonoids from Koelreuteria henryi and other sources as protein tyrosine kinase inhibitors. J Nat Prod. 56:967–969. 1993.
15	Chang CJ, Ashendel CL, Geahlen RL, McLaughlin JL and Waters DJ: Oncogene signal transduction inhibitors from medicinal plants. In Vivo. 10:185–190. 1996.PubMed/NCBI
16	Lee TH, Chiang YH, Chen CH, Chen PY and Lee CK: A new flavonol galloylrhamnoside and a new lignan glucoside from the leaves of Koelreuteria henryi Dummer. J Nat Med. 63:209–214. 2009. View Article : Google Scholar : PubMed/NCBI
17	Abou-Shoer M, Ma GE, Li XH, Koonchanok NM, Geahlen RL and Chang CJ: Flavonoids from Koelreuteria henryi and other sources as protein-tyrosine kinase inhibitors. J Nat Prod. 56:967–969. 1993.
18	Song YN, Zhang HL, Chang CJ and Bollag DM: Cytotoxic cyclolignans from Koelreuteria henryi. J Nat Prod. 57:1670–1674. 1994. View Article : Google Scholar : PubMed/NCBI
19	Chen CH, Chan HC, Chu YT, et al: Antioxidant activity of some plant extracts towards xanthine oxidase, lipoxygenase and tyrosinase. Molecules. 14:2947–2958. 2009. View Article : Google Scholar : PubMed/NCBI
20	Lin CY, Chen PN, Hsieh YS and Chu SC: Koelreuteria formosana extract impedes in vitro human LDL and prevents oxidised LDL-induced apoptosis in human umbilical vein endothelial cells. Food Chem. 146:299–307. 2014. View Article : Google Scholar
21	Ho ML, Hsieh YS, Chen JY, Chen KS, Chen JJ, Kuo WH, Lin SJ and Chen PN: Antimetastatic potentials of Dioscorea nipponica on Melanoma in vitro and in vivo. Food Chem Toxicol. 50:558–66. 2012.
22	Chu SC, Chiou HL, Chen PN, Yang SF and Hsieh YS: Silibinin inhibits the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2. Mol Carcinog. 40:143–149. 2004. View Article : Google Scholar : PubMed/NCBI
23	Chen PN, Hsieh YS, Chiang CL, Chiou HL, Yang SF and Chu SC: Silibinin inhibits invasion of oral cancer cells by suppressing the MAPK pathway. J Dent Res. 85:220–225. 2006. View Article : Google Scholar : PubMed/NCBI
24	Chu SC, Yang SF, Liu SJ, Kuo WH, Chang YZ and Hsieh YS: In vitro and in vivo antimetastatic effects of Terminalia catappa L. leaves on lung cancer cells. Food Chem Toxicol. 45:1194–1201. 2007. View Article : Google Scholar : PubMed/NCBI
25	Kim HJ, Kim YM, Lim S, et al: Ubiquitin C-terminal hydrolase-L1 is a key regulator of tumor cell invasion and metastasis. Oncogene. 28:117–127. 2009. View Article : Google Scholar : PubMed/NCBI
26	Lo C, Lai TY, Yang JS, et al: Gallic acid inhibits the migration and invasion of A375.S2 human melanoma cells through the inhibition of matrix metalloproteinase-2 and Ras. Melanoma Res. 21:267–273. 2011. View Article : Google Scholar
27	Ho HH, Chang CS, Ho WC, Liao SY, Wu CH and Wang CJ: Anti-metastasis effects of gallic acid on gastric cancer cells involves inhibition of NF-kappaB activity and downregulation of PI3K/AKT/small GTPase signals. Food Chem Toxicol. 48:2508–2516. 2010. View Article : Google Scholar
28	Peng CY, Yang HW, Chu YH, et al: Caffeic acid phenethyl ester inhibits oral cancer cell metastasis by regulating matrix metalloproteinase-2 and the mitogen-activated protein kinase pathway. Evid Based Complement Alternat Med. 2012:7325782012.PubMed/NCBI
29	Chung TW, Moon SK, Chang YC, et al: Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism. FASEB J. 18:1670–1681. 2004. View Article : Google Scholar
30	Noel A, Maillard C, Rocks N, Jost M, Chabottaux V, Sounni NE, Maquoi E, Cataldo D and Foidart JM: Membrane associated proteases and their inhibitors in tumour angiogenesis. J Clin Pathol. 57:577–584. 2004. View Article : Google Scholar : PubMed/NCBI
31	Kawata N, Nagane Y, Hirakata H, et al: Significant relationship of matrix metalloproteinase 9 with nuclear grade and prognostic impact of tissue inhibitor of metalloproteinase 2 for incidental clear cell renal cell carcinoma. Urology. 69:1049–1053. 2007. View Article : Google Scholar
32	Takahashi M, Oka N, Naroda T, et al: Prognostic significance of matrix metalloproteinases-2 activation ratio in renal cell carcinoma. Int J Urol. 9:531–538. 2002. View Article : Google Scholar : PubMed/NCBI
33	Harada K, Sakai I, Ishimura T, Inoue TA, Hara I and Miyake H: Clinical symptoms in localized renal cell carcinoma reflect its invasive potential: comparative study between incidentally detected and symptomatic diseases. Urol Oncol. 24:201–206. 2006. View Article : Google Scholar
34	Kallakury BV, Karikehalli S, Haholu A, Sheehan CE, Azumi N and Ross JS: Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma. Clin Cancer Res. 7:3113–3119. 2001.PubMed/NCBI
35	Liu KC, Huang AC, Wu PP, et al: Gallic acid suppresses the migration and invasion of PC-3 human prostate cancer cells via inhibition of matrix metalloproteinase-2 and -9 signaling pathways. Oncol Rep. 26:177–184. 2011.PubMed/NCBI
36	Huang Z, Yan DP and Ge BX: JNK regulates cell migration through promotion of tyrosine phosphorylation of paxillin. Cell Signal. 20:2002–2012. 2008. View Article : Google Scholar : PubMed/NCBI
37	Chang HR, Chen PN, Yang SF, et al: Silibinin inhibits the invasion and migration of renal carcinoma 786-O cells in vitro, inhibits the growth of xenografts in vivo and enhances chemosensitivity to 5-fluorouracil and paclitaxel. Mol Carcinog. 50:811–823. 2011. View Article : Google Scholar